Antibodies News and Research

RSS
Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

Researchers to investigate COVID-19's disproportionate impact on long-term care residents and workers

Researchers to investigate COVID-19's disproportionate impact on long-term care residents and workers

Research shows a causal relationship between neonatal antibody production and maternal microbiota

Research shows a causal relationship between neonatal antibody production and maternal microbiota

Vaccine candidate shows promise to protect against dozen-plus flu strains

Vaccine candidate shows promise to protect against dozen-plus flu strains

Researchers develop ultrapotent miniproteins that target SARS-CoV-2 receptor-binding domain

Researchers develop ultrapotent miniproteins that target SARS-CoV-2 receptor-binding domain

Obesity may reduce COVID-19 vaccine efficacy, say researchers

Obesity may reduce COVID-19 vaccine efficacy, say researchers

Researchers examine long-term immune responses following COVID-19 across clinically diverse cohort

Researchers examine long-term immune responses following COVID-19 across clinically diverse cohort

Novel SARS-CoV-2 spike vaccine candidate produces strong neutralizing response in vivo

Novel SARS-CoV-2 spike vaccine candidate produces strong neutralizing response in vivo

Early antibody response predicts COVID-19 outcome

Early antibody response predicts COVID-19 outcome

Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers

Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers

Survey reveals impact of Pfizer-BioNTech vaccination in the UK

Survey reveals impact of Pfizer-BioNTech vaccination in the UK

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

Readers and tweeters dispense timely advice for difficult times

Readers and tweeters dispense timely advice for difficult times

Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model

SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

Experimental therapy delays viral rebound in SHIV-infected macaques

Experimental therapy delays viral rebound in SHIV-infected macaques

Biological activity-based modeling offers a new approach for drug discovery

Biological activity-based modeling offers a new approach for drug discovery

Emerging protein-based immunotherapies could lead to highly effective cancer treatments

Emerging protein-based immunotherapies could lead to highly effective cancer treatments